Biofil Chemicals And Pharmaceuticals Limited - Company Profile

It is a chemicals and materials public limited company based in Indore, Madhya Pradesh, India, established in 1985.

1985 Indore, Madhya Pradesh, India Active

Last Updated: December 23, 2025

About Biofil Chemicals And Pharmaceuticals Limited

Biofil Chemicals And Pharmaceuticals Limited, a active public limited company, was established on 04 January 1985 in Indore, Madhya Pradesh, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: L24233MP1985PLC002709. Registered under ROC Roc Gwalior. it is listed on BSE: 524396 and NSE: BIOFILCHEM. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹16.27 Cr.

Formerly known as Biofil Chemicals And Pharmaceuticals Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹30.13 Cr and a net worth of ₹17.30 Cr. Employing 19 professional, Its leadership includes Ketan Shah (Managing Director), Gayatri Padiyar (Director), Ashok Kumar Ramawat (Director). Past directors included Ramesh Chimanlal Shah, Ketan Shah, Gayatri Padiyar. It holds ₹2.85 Cr open charges and ₹14.00 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at B/12-B, Industrial Estate, Pologround,, Indore, Madhya Pradesh, 452015.

Company Details

CIN/LLPIN
L24233MP1985PLC002709
Registration Number
002709
Incorporation Date
04 January 1985
Authorized Capital
₹20.00 Cr
Paid-Up Capital
₹16.27 Cr
ROC Code
Roc Gwalior
Listing Status
Listed (BSE: 524396, NSE: BIOFILCHEM)
Company Status
Active

Key Metrics

Authorised Capital ₹ 20.00 Cr as on 23-12-2025
Paid Up Capital ₹ 16.27 Cr as on 23-12-2025
Company Age 41 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 2.85 Cr as on 23-12-2025
Satisfied Charges ₹ 14.00 Cr as on 23-12-2025
Revenue Growth **** 33.73% (FY 2023)
Profit Growth **** -19.76% (FY 2023)
Ebitda **** -12.39% (FY 2023)
Net Worth 2.76% (FY 2023)
Total Assets **** 67.66% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Biofil Chemicals And Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Biofil Chemicals And Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ketan Shah	Managing Director	25 Aug 2020	Current
Gayatri Padiyar	Director	14 Aug 2023	Current
Ashok Kumar Ramawat	Director	25 Aug 2020	Current
Satish Beohar	Director	30 Jun 2021	Current
Meet Shah	Director	30 Dec 2024	Current
Smitesh Shah	Director	23 Aug 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	22 Sep 2014	Past
Pramod Abcsdd	Whole-Time Director	28 Sep 2020	Past
Pramod Abcsdd	Additional Director	26 Sep 2023	Past
Pramod Abcsdd	Managing Director	26 Sep 2021	Past
Pramod Abcsdd	Additional Director	29 Sep 2020	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biofil Chemicals And Pharmaceuticals.

Biofil Chemicals And Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.73% increase. The company also saw a substantial fall in profitability, with a 19.76% decrease in profit. The company's net worth moved up by a moderate rise of 2.76%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

33.73%

*******

Revenue from Operations

*******

34.19%

*******

Total Assets

*******

67.66%

*******

Profit or Loss

*******

-19.76%

*******

Net Worth

*******

2.76%

*******

EBITDA

*******

-12.39%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biofil Chemicals And Pharmaceuticals?

In 2023, Biofil Chemicals And Pharmaceuticals had a promoter holding of 46.82% and a public holding of 53.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹28,500,000.00

Satisfied Charges

₹140,000,000.00

Charges Breakdown by Lending Institutions

Others : 2.85 Cr

Latest Charge Details

Date	Lender	Amount	Status
03 Sep 2025	Others	₹2.85 Cr	Open
07 Dec 1998	Industrial Development Bank Of India	₹4.00 Cr	Satisfied
12 Jul 1996	Canara Bank	₹0.00	Satisfied
12 Sep 1995	Industrial Development Bank Of India	₹10.00 Cr	Satisfied
13 Mar 1995	Canara Bank	₹0.00	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Biofil Chemicals And Pharmaceuticals?

Biofil Chemicals And Pharmaceuticals has a workforce of 19 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Biofil Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofil Chemicals And Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biofil Chemicals And Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Biofil Chemicals And Pharmaceuticals Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was completed.
27 Sep 2025
Charges

Progress on A charge with Others amounted to Rs. 2.85 Cr with Charge ID 101154175 was registered on 03 Sep 2025. was documented.
03 Sep 2025
Director Appointment

The activity Smitesh Shah was appointed as a Director was appointed as a Director on 23 Aug 2025 & has been associated with this company since 6 months 7 days . was completed.
23 Aug 2025
Director Appointment

Apoorv Jain was appointed as a Company Secretary was appointed as a Company Secretary on 26 Apr 2025 & has been associated with this company since 10 months 3 days . was recorded as a recent event.
26 Apr 2025
Balance Sheet

Biofil Chemicals And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.
31 Mar 2025
Director Appointment

Progress on Meet Shah was appointed as a Director was appointed as a Director on 30 Dec 2024 & has been associated with this company since 1 year 2 months . was documented.
30 Dec 2024

Explore recent activity and updates - View Recent Activity